The Abramson Cancer Center of the University of Pennsylvania
Last Modified: January 2, 2002
Dec 18, 2014 - A novel gene therapy for glioblastoma multiforme utilizing a combination of adenoviral vectors and the drug ganciclovir is nearing clinical trial with the discovery of a biomarker to gauge tumor response to the treatment, according to a study reported in the July 1 issue of Clinical Cancer Research.
Dec 18, 2014
Apr 16, 2010
Nov 30, 2010